Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
10/2008
10/30/2008US20080268547 Systems and Methods for Indicating Oxidation of Consumer Products
10/30/2008US20080268546 Detection of dna hybridization on surfaces
10/30/2008US20080268545 Using magnetism to separate metal particles comprising oligonucleotides hybridized to immobilized DNA probes
10/30/2008US20080268536 Humanized Anti-CCR2 Antibodies and Methods of Use Therefor
10/30/2008US20080268528 Self-contained, stand alone multicomparatment apparatus for use in cyclic replication of preferential nucleotide sequences
10/30/2008US20080268509 Methods of labeling polynucleotides with energy transfer dyes
10/30/2008US20080268505 Preparing preferential nucleotide sequences via DNA repair and heteroduplex conversion; directed protein evolution
10/30/2008US20080268499 Nucleotide sequences coding hormone recptors for use in identifying modulaors of insect propagation; biological pest control; insecticides
10/30/2008US20080268497 Using mixture comprising digestive enzyme and gold particles to prepare tissue for mass spectrum proteomic analysis
10/30/2008US20080268494 Using scattered light to generate hemoglobin profiles for use in diagnosing blood disorders; evaluating efficacy of therapeutic treatments
10/30/2008US20080268493 Using silver and/or gold nanoparticles to enhance light scattering and to generate bacterial identification and classification profiles
10/30/2008US20080268492 Identifying nutrient mixture which enhances cryogenic protection of suspended tissues
10/30/2008US20080268490 Methods for in vitro growth of hair follicles
10/30/2008US20080268489 Therapeutic polypeptide for use in treatment of heart, hypothermic and cardiovascular disorders
10/30/2008US20080268488 Screening Method for Dnak Inhibitors
10/30/2008US20080268487 Method For Identifying Agents Which Modulate GtpPase Activity Involved in Insulin-Stimulated Glut4 Translocation
10/30/2008US20080268486 Apparatus for determining concentration of glucose and acetone in fluid
10/30/2008US20080268485 Iconic Display of Markers for a Meter
10/30/2008US20080268484 Using thrombin-antithrombin III complex as tool in identifying modulators of glypican-3 expression; treating arteriosclerosis
10/30/2008US20080268483 Using clot formation and proteolysis as evaluative indicators of heart, blood, liver and kidney disorders; drug screening
10/30/2008US20080268482 Colorimetric analysis; kits
10/30/2008US20080268476 Nectin 4 (N4) as a Marker for Cancer Prognosis
10/30/2008US20080268471 For use in foods, beverages, and drugs
10/30/2008US20080268470 Methods of selecting cell clones
10/30/2008US20080268469 Systems and Methods for Analyzing a Particulate
10/30/2008US20080268468 Alkynyl sugar analogs for the labeling and visualization of glycoconjugates in cells
10/30/2008US20080268464 Apparatus for identifying modulators of papain activity; drug screening; monitoring drug efficacy
10/30/2008US20080268461 Method of Measuring Cholesterol in Remnant-Like Lipoproteins
10/30/2008US20080268460 Assays to Identify Irreversibly Binding Inhibitors of Receptor Tyrosine Kinases
10/30/2008US20080268458 Conjugating oligonuclotide probe to nanoparticle, denaturing test sampe exposing to probe, screening for hybridized nucleotide sequences
10/30/2008US20080268457 siRNA targeting forkhead box P3 (FOXP3)
10/30/2008US20080268456 Method for detecting and quantitating multiple-subcellular components
10/30/2008US20080268455 Detection of nuceic acids by multiple sequential invasive cleavages
10/30/2008US20080268454 Compositions, methods and systems for inferring bovine breed or trait
10/30/2008US20080268453 Types of lymphoma and method for prognosis thereof
10/30/2008US20080268452 Nucleotide sequences soecific to 23s ribosomal nucleic acid for use as screening tools in detection of microorganisms in bioprocesses, food, water and industrial samplings
10/30/2008US20080268451 Measurement of an insoluble analyte in a sample
10/30/2008US20080268450 Using porous ligand conjugated microparticle probe to screen for preferential nucleic acids, proteins, peptides, metal ions, haptens, drugs, metabolites, pesticides and/or pollutants
10/30/2008US20080268449 Using variant serine/threonine kinase (B-RAF) expression as screening tool in detection of cell proliferative disorders
10/30/2008US20080268448 Multiplex compositions and methods for quantification of human nuclear DNA and human male DNA and detection of PCR inhibitors
10/30/2008US20080268447 Sequential Cloning System
10/30/2008US20080268446 Superimposed, multilayer, hermetically sealed
10/30/2008US20080268445 Rodent model comprising mutation in adenine nucleotide translocator (ANT) gene for use in identifying modulators for prevention and treatment of cardiac disorders
10/30/2008US20080268444 Using single stranded nucleotide sequences to identify mutation in DNA repair gene (MutS)
10/30/2008US20080268443 Broad-based disease association from a gene transcript test
10/30/2008US20080268442 Method and system for preparing a blood sample for a disease association gene transcript test
10/30/2008US20080268441 Detectable labeled nucleoside analogs and methods of use thereof
10/30/2008US20080268440 Biomolecule immobilization on surface via hydrophobic interactions
10/30/2008US20080268439 Using cells expressing potassium channel (SK2) proteins as tool in identifying modulator for prevention and treatment of neuropathic pain and nervous system disorders
10/30/2008US20080268438 Model system for identifying anti-cancer agents
10/30/2008US20080268437 Immobilized primer for use in determining sequence of preferential DNA species; genomics; gene expression analysis
10/30/2008US20080268436 Schizophrenia, Schizoaffective Disorder and Bipolar Disorder Susceptibility Gene Mutation and Applications to Their Diagnosis and Treatment
10/30/2008US20080268435 Using psoriasin gene expression profile as evaluative tool in determining functionality of breast cancer gene
10/30/2008US20080268434 Using enclosed structure for cyclic amplification of polynucleotide sequences
10/30/2008US20080268433 Using presence of genetic variation in mitochondrial D-loop DNA as diagnostic/predictive indicator of cell proliferative disorders
10/30/2008US20080268432 Method for detection of staphylococcus epidermidis
10/30/2008US20080268431 Encapsulating within double layer metal hydroxide; electrophoresis
10/30/2008US20080268430 Methods and Kits Pertaining to the Detection, Identification and Quantification of Bacteria and Yeast in Wine, Beer and Juices
10/30/2008US20080268429 Rna - Containing Microvesicles and Methods Therefor
10/30/2008US20080268428 Chromosome 5 Genetic Variants Related to Dyslexia
10/30/2008US20080268427 Using presence of viral gp48 polypeptide in follicles of cattle as diagnostic indicator of viral disease; veterinary medicine
10/30/2008US20080268426 Identifying virally infected and vaccinated organisms
10/30/2008US20080268425 Methods and kits for detecting classical swine fever virus
10/30/2008US20080268424 Glut-1 as a Receptor for Htlv Envelopes and its Uses
10/30/2008US20080268423 Using immobilized envelope protein domain as tools to identify immunoglobulins generate in response to tick borne encephalitis viral and/or west nile viral infections
10/30/2008US20080268422 Pressurized flow apparatus comprising growth cassette and filtration unit for monitoring growth of preferential microorganisms
10/30/2008US20080268421 Bile acid derivatives, cholesterol esterase, cholesterol dehydrogenase, coenzyme, and redox agent capable of being oxidised or reduced; analyzes high and low density lipoproteins; kits
10/30/2008US20080268420 Using b-cells as targeting tools for recovery of preferential tumor antigen specific immunoglobulins; tissue targeted therapy; antitumor agents; diagnosing cell proliferative disorders
10/30/2008US20080268068 methods and kits for determining the presence or absence of a SPARC promoter mutation indicative of a cancer's resistance or sensitivity to a therapeutic regimen
10/30/2008US20080267999 Neoepitope detection of disease using protein arrays
10/30/2008US20080267990 Nucleotide sequences coding interferon inducer for use in detection of mycobacterial infection
10/30/2008US20080267989 Self aggregating monomeric fusion protein for use in induction of immune response to human immunodeficiency viral infection
10/30/2008US20080267975 Using lymphocyte profiles comprising aberrant transmembrane receptor tyrosine kinase (Mer) expression as evaluative tool in screening for blood clotting and/or cell proliferative disorders
10/30/2008US20080267973 Diagnosis and Treatment of Siglec-6 Associated Diseases
10/30/2008US20080267967 Modulation of cd200 receptors
10/30/2008US20080267958 Lymphatic endothelial glycoprotein for use as tool in identifying modulators for prevention and treatment of inflammation and cell proliferative disorders
10/30/2008US20080267955 Frizzled 9 as tumor marker
10/30/2008US20080267951 Methods for Treating Cancer Using Agents That Inhibit Wnt16 Signaling
10/30/2008US20080267944 Expression vector comprising nucleotide sequences coding serine potease like protein for use in depleting fibrinogen from blood and diagnosing dysprothrombinemias
10/30/2008US20080267929 Use of stem cells to generate inner ear cells
10/30/2008US20080267909 Using acetyl-low density lipoprotein (acetyl-LDL) and an acyl-coenzyme A:cholesterol acyltransferase (ACAT) inhibitor as stimulatory tools in identifying modulators which treat and/prevent heart, cardiovascular and diabetic disorders
10/30/2008US20080267887 Such as 5-(2,6-diethyl-phenyl)-1H-pyrrolo[2,3-C]pyridine, which binds C5a receptors with high affinity; for treatment of inflammatory, cardiovascular, and immune system disorders; kits
10/30/2008US20080267877 Administering carrier molecule such as albumin conjugated to mannose-6-phosphate; particularly targeting Hepatic Stellate Cells (HSC); glomeruloscherosis, interstitial fibrosis, lung fibrosis, atherosclerosis, Crohn's disease, colitis ulcerosa, glomerulonephritis and sepsis; diagnosis
10/30/2008US20080267874 Targeted Neuronal And Glial Human Embryonic Stem Cell Line
10/30/2008US20080267872 The 98P4B6 gene, its fragment, its encoded protein, variants , or a fragment, can be used to elicit a humoral or cellular immune response; antibodies or T cells reactive with 98P4B6 can be used in active or passive immunization
10/30/2008US20080267863 Method of Diagnosing, Monitoring, Staging, Imaging and Treating Colon Cancer
10/30/2008US20080265213 Mixing powdered dye with evaporable solvent, applying mixture to dye carrier material, allowing solvent to evaporate resulting in plurality of dye solids being dispersed on dye carrier material, and applying liquid to carrier; for a closed air-conditioning or refrigeration system
10/30/2008DE10217597B4 Verfahren und Vorrichtung zur elektrochemischen Immobilisierung von Biomolekülen Method and apparatus for the electrochemical immobilization of biomolecules
10/30/2008DE102007020982A1 Visual identification of original product for its authentication by contrast adjustment by providing micro assembly, involves utilizing single random micro assembly made from random surface distributed micro assembly elements
10/30/2008CA2697357A1 Cardibioindex/cardibioscore and utility of salivary proteome in cardiovascular diagnostics
10/30/2008CA2685557A1 Functional toll-like receptors (tlr) on melanocytes and melanoma cells and uses thereof
10/30/2008CA2685160A1 Broad-based disease association from a gene transcript test
10/30/2008CA2684707A1 Mo-1, a gene associated with morbid obesity
10/30/2008CA2684570A1 Methods, compositions and kits for detection and analysis of antibiotic-resistant bacteria
10/30/2008CA2684465A1 Methods for counting cells
10/30/2008CA2684311A1 Microorganism detection method and apparatus
10/30/2008CA2684271A1 Methods and compositions for selecting soybean plants resistant to phytophthora root rot
10/30/2008CA2683854A1 Epigenetic biomarkers for early detection, therapeutic effectiveness, and relapse monitoring of cancer
10/30/2008CA2683836A1 Method for determination of progression risk of glaucoma
10/30/2008CA2683691A1 Method for determination of onset risk of glaucoma